top biopharmaceuticals for glp-1 medication Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch GLP-1R Agonists for Weight Loss

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Huang Y, He Y, Makarcyzk MJ, Lin H Frontiers in Bioengineering and Biotechnology (2021) This study demonstrated that FOXO4-DRI selectively removes senescent cells from human chondrocyte cultures expanded in vitro, providing direct evidence of the peptide's senolytic activity in human cells relevant to joint and cartilage aging

Preclinical studies dosed mice, not people, and no human trials were found

This happens when fluid and immune cells accumulate around clogged follicles

The financial barrier is hardly insignificant

C.RobbinsM